To assess the impact of a group medical clinic designed for patient with type 2 diabetes mellitus and hypertension on body mass index.
Methods
Using data from a randomized trial of 239 veterans with type 2 diabetes mellitus, we performed a secondary analysis using analysis of covariance mixed models to explore the effect of a 12-month group medical clinic intervention on change in body mass index vs. usual care. In an exploratory subgroup analysis, we compared change in body mass index between treatment arms stratified by whether patients had >0.5% reduction in hemoglobin A1c at 12 months.
Results
Baseline body mass index was 33.5 kg/m2. At 12 months, there was no significant difference in change in body mass index between treatment arms (estimate=−0.02, 95% CI −0.51 to 5.05; P = 0.94); body mass index increased by approximately 0.20 points in both groups. There was also no significant difference in change in body mass index between treatment arms by whether or not patients had >0.5% reduction in hemoglobin A1c (estimate=−0.14, 95% CI −1.21 to −0.92; P = 0.79).
Discussion
Improved glycemic control was not associated with improved body mass index in the group medical clinic intervention. Given their positive effects on other outcomes, group medical clinics for patients with type 2 diabetes mellitus may be more beneficial if focus is shifted towards weight loss.
PontiroliAMieleLMorabitoA.Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: Systematic review and meta‐analysis. Diabetes Obes Metabol2011;
13: 1008–1019.
2.
EdelmanDGierischJMMcDuffieJR, et al.
Shared medical appointments for patients with diabetes mellitus: A systematic review. J Gen Intern 2015; 30(1): 99–106.
3.
EdelmanDFredricksonSKMelnykSD, et al.
Medical clinics versus usual care for patients with both diabetes and hypertension—A randomized trial. Ann Intern Med2010;
152: 689–696.
4.
ScottJGadeGMcKenzieM, et al.
Cooperative health care clinics: A group approach to individual care. Geriatrics1998;
53: 68–70. 6–8, 81; quiz 2.
5.
JaberRBraksmajerATrillingJ.Group visits for chronic illness care: Models, benefits and challenges. Fam Pract Manage2006;
13: 37.
6.
BurkeREO’GradyET.Group visits hold great potential for improving diabetes care and outcomes, but best practices must be developed. Health Affairs2012;
31: 103–109.
7.
DeakinTMcShaneCECadeJE, et al.
Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev2005;
2: CD003417.
8.
EdelmanDGierischJMMcDuffieJR, et al.
Shared medical appointments for patients with diabetes mellitus: A systematic review. J Gen Intern Med2015;
30: 99–106.
9.
PanSYJohnsonKCUgnatA-M, et al.
Association of obesity and cancer risk in Canada. Am J Epidemiol2004;
159: 259–268.
10.
LiDMorrisJSLiuJ, et al.
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA2009;
301: 2553–2562.
11.
QuesenberryCPCaanBJacobsonA.Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med1998;
158: 466–472.
12.
CommitteeFFMPL.The future of family medicine: A collaborative project of the family medicine community. Ann Fam Med2004;
2: S3–S32.
13.
CrowleyMJMelnykSDCoffmanCJ, et al.
Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention. Diabetes Care2013;
36: 1954–1960.
14.
BounthavongMTranJGolshanS, et al.
Retrospective cohort study evaluating exenatide twice daily and long-acting insulin analogs in a Veterans Health Administration population with type 2 diabetes. Diabetes Metabol2014;
40: 284–291.
15.
RossSADzidaGVoraJ, et al.
Impact of weight gain on outcomes in type 2 diabetes. Curr Med Res Opin2011;
27: 1431–1438.
16.
NorrisSLZhangXAvenellA, et al.
Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: A meta-analysis. Am J Med2004;
117: 762–774.
17.
Statements Q. Management of diabetes mellitus. Update, 2010.
18.
KramerHReboussinDBertoniAG, et al.
Obesity and albuminuria among adults with type 2 diabetes. Diabetes Care2009;
32: 851–853.
19.
SohnMWBudiman-MakELeeTA, et al.
Significant J‐shaped association between body mass index (BMI) and diabetic foot ulcers. Diabetes Metab Res Rev2011;
27: 402–409.
20.
KirkJKGravesDECravenTE, et al.
Restricted-carbohydrate diets in patients with type 2 diabetes: A meta-analysis. J Am Diet Assoc2008;
108: 91–100.
21.
FranzMJPowersMALeontosC, et al.
The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc2010;
110: 1852–1889.
22.
FeinmanRDPogozelskiWKAstrupA, et al.
Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. Nutrition2015;
31: 1–13.
23.
GudzuneKADoshiRSMehtaAK, et al.
Efficacy of commercial weight-loss programs: An updated systematic review. Ann Intern Med2015;
162: 501–512.
24.
TsaiAGWaddenTA.Systematic review: An evaluation of major commercial weight loss programs in the United States. Ann Intern Med2005;
142: 56–66.
25.
ChristakisNAFowlerJH.The spread of obesity in a large social network over 32 years. N Engl J Med2007;
357: 370–379.
26.
Paul-EbhohimhenVAvenellA.A systematic review of the effectiveness of group versus individual treatments for adult obesity. Obes Facts2009;
2: 17–24.
27.
ChanSHRaffaSD.Examining the dose–response relationship in the Veterans Health Administration’s MOVE!® Weight Management Program: A nationwide observational study. J Gen Intern Med2017;
32: 18–23.
28.
BraunKEricksonMUtechA, et al.
Evaluation of veterans MOVE! program for weight loss. J Nutr Educ Behav2016;
48: 299–303.e1.
29.
GarvinJTMarionLNNarsavageGL, et al.
Characteristics influencing weight reduction among veterans in the MOVE!® Program. West J Nurs Res2015;
37: 50–65.
30.
KahwatiLCLewisMAKaneH, et al.
Best practices in the Veterans Health Administration's MOVE! Weight management program. Am J Prev Med2011;
41: 457–464.
31.
MoinTDamschroderLJAuYoungM, et al.
Diabetes prevention program translation in the Veterans Health Administration. Am J Prev Med2017;
53(1): 70–77.
32.
HuTMillsKTYaoL, et al.
Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: A meta-analysis of randomized controlled clinical trials. Am J Epidemiol2012;
176: S44–S54.
33.
SantosFEstevesSda Costa PereiraA, et al.
Systematic review and meta‐analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev2012;
13: 1048–1066.
34.
WheelerMLDunbarSAJaacksLM, et al.
Macronutrients, food groups, and eating patterns in the management of diabetes. Diabetes Care2012;
35: 434–445.
